Rchr
J-GLOBAL ID:201501019156530378
Update date: Nov. 16, 2024
Yamamoto Yukiya
ヤマモト ユキヤ | Yamamoto Yukiya
Affiliation and department:
Job title:
Professor
Homepage URL (1):
https://www.researchgate.net/profile/Yukiya-Yamamoto
Research field (3):
Molecular biology
, Tumor diagnostics and therapeutics
, Hematology and oncology
Research keywords (12):
gene mutations
, chromosomal translocation
, disease models
, kinase inhibitors
, MPN
, signal transduction
, AML
, transcription factors
, tumor supressor
, APL
, phage library
, therapeutic antibody
Research theme for competitive and other funds (3):
- 2016 - 2020 Identification and functional analysis of gene aberrations in hematological malignancy with complex chromosomal abnormality using RNA-seq analysis
- 2011 - 2015 Leukemogenic property of acute promyelocytic leukemia gene, BCOR-RARA
- 2006 - 2007 急性骨髄性白血病抗原に対する網羅的探索と新規抗体療法開発のための基礎的研究
Papers (44):
-
Yukiya Yamamoto, Sachiko Iba, Yoko Inaguma, Akinao Okamoto, Akihiro Abe. ELC52: a novel megakaryocytic leukemia cell line with a CALR type 1 mutation. Leukemia. 2024
-
Yoichiro Ogama, Yuji Kumagai, Norio Komatsu, Marito Araki, Nami Masubuchi, Hiroko Akiyoshi, Tadashi Matsuura, Hiromi Kirisako, Akiko Kyoya, Fumiko Nomura, et al. Phase 1 Clinical Trial of PPMX-T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics. Clinical Pharmacology in Drug Development. 2022. 12. 6. 579-587
-
Xinhui Zhao, Boris Bartholdy, Yukiya Yamamoto, Erica K. Evans, Meritxell Alberich-Jordà, Philipp B. Staber, Touati Benoukraf, Pu Zhang, Junyan Zhang, Bon Q. Trinh, et al. PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development. Communications Biology. 2022. 5. 1
-
Kentaro Hirade, Shigeru Kusumoto, Akihiro Abe, Hatsune Noritake, Asahi Ito, Masaki Ri, Hirokazu Komatsu, Shinsuke Iida, Yukiya Yamamoto. A novel RARA-SNX15 fusion in PML-RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1). International Journal of Hematology. 2022. 116. 6. 956-960
-
Akinao Okamoto, Hidetsugu Fujigaki, Chisako Iriyama, Naoe Goto, Hideyuki Yamamoto, Keichiro Mihara, Yoko Inaguma, Yasuo Miura, Katsuya Furukawa, Yukiya Yamamoto, et al. CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma. Blood Advances. 2022. 6. 11. 3230-3233
more...
MISC (87):
-
平出 賢太郎, 山本 幸也, 安部 明弘, 楠本 茂, 河合 秋美, 白神 一秀, 中村 智幸, 大岩 加奈, 鈴木 智貴, 木下 史緒理, et al. 新規融合遺伝子RARA-SNX15を伴った急性前骨髄球性白血病の一例(A novel fusion transcript RARA-SNX15 in an APL case harboring t(11;17;15)(q13;q21.2;q24.1)). 日本血液学会学術集会. 2021. 83回. OS3-3
-
山本 秀行, 入山 智沙子, 村手 健一郎, 伊庭 佐知子, 岡本 晃直, 山本 幸也, 徳田 倍将, 岡部 麻子, 島 寛太, 安田 貴彦, et al. 髄液遊離DNAの遺伝子変異解析が有用であった中枢神経症状で発症したMYD88変異陽性骨原発DLBCLの1例. 日本リンパ網内系学会会誌. 2020. 60. 78-78
-
水谷 有希, 佐藤 聖子, 大澤 道子, 渡邉 文子, 西井 智香子, 山本 幸也, 勝田 逸郎, 富田 章裕. 急性巨核芽球性白血病の一例. 日本検査血液学会雑誌. 2020. 21. 学術集会. S147-S147
-
安部明弘, 山本幸也, 山本幸也, 山本秀行, 岡本晃直, 稲熊容子, 入山智沙子, 徳田倍将, 岡本昌隆, 恵美宣彦, et al. t(6;9;22)(q25;q34;q11.2)を有するBCR-ABL1陽性慢性骨髄性白血病に認められたARID1B-EMID1融合遺伝子. 日本血液学会学術集会抄録(Web). 2020. 82nd
-
入山智沙子, 村手健一郎, 伊庭佐知子, 岡本晃直, 山本秀行, 徳田倍将, 山本幸也, 岡本昌隆, 渡辺宏久, 冨田章裕. 中枢神経悪性リンパ腫における髄液由来DNAを用いた高感度解析法の確立. 日本血液学会学術集会抄録(Web). 2020. 82nd
more...
Books (1):
-
ビジュアル臨床血液形態学(改訂第4版)
南江堂 2021
Lectures and oral presentations (45):
-
Phase I Safety Study of Anti-Transferrin Receptor 1 Antibody (PPMX-T003) in Patients with Polycythemia Vera and Erythrocythemia
(ASH Annual Meeting 2024)
-
骨髄線維症の新たな治療戦略
(Myelofibrosis Web Seminar 2024)
-
再生不良性貧血の診断と薬物治療
(ITP・AA診療 webセミナー 2024)
-
ET診療における実践的アプローチ:リスク別管理と薬剤の使い分け
(東海Hematology seminar 2024)
-
Diagnosis and treatment of essential thrombocythemia
(ET camp 2022 in December 2022)
more...
Education (2):
- 1998 - 2002 Nagoya University graduate school of medicine
- 1987 - 1993 Nagoya University School of Medicine
Professional career (1):
- M.D., Ph.D. (Nagoya University)
Work history (9):
- 2020/04 - 現在 Chubu University College of Life and Health Sciences, Department of Biomedical Sciences Professor
- 2020/03 - 現在 Fujita Health University Department of Medicine Visiting associate professor
- 2020/03 - 現在 Fujita Health University Hospital Hematology & Chemotherapy Visiting Physician
- 2018/10 - 2020/03 Fujita Health University Hematology Associate Professor
- 2017/04 - 2018/10 Fujita Health University Hematology Associate Professor
- 2005/04 - 2017/03 Fujita Health University Hematology Senior Assistant Professor
- 2002/04 - 2004/12 Harvard Medical School Beth Israel Deaconess Medical Center Research Fellow
- 1995/04 - 1998/03 Nagoya Ekisaikai Hospital Fellow (internal medicine)
- 1993/04 - 1995/03 Nagoya Ekisaikai Hospital Resident
Show all
Committee career (5):
- 2020/08 - 現在 Perseus Proteomics Inc. Medical Expert
- 2017/11 - 現在 MPN-JAPAN Medical Expert
- 2016/09 - 現在 Japanese Society of Hematology Councilor
- 2023/06 - 2024/05 Japanese Society of Hematology Curator of Genomic Testing Guidelines
- 2022/08 - 2024/05 National Cancer Center Japan C-CAT curator
Awards (2):
- 2008/11 - Medical Research Fellowship of Takeda Science Foundation
- 2003/11 - KYO Award of Japanese Leukaemia Research Fund
Association Membership(s) (4):
American Society of Hematology
, THE JAPANESE CANCER ASSOCIATION
, THE JAPANESE SOCIETY OF HEMATOLOGY
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE
Return to Previous Page